02/18/2007 - A GROWING industry is hoping to spin gold from DNA's double helixes by using ultrasensitive genetic tests to personalize medical treatment for cancer, lupus and other diseases.
These molecular diagnostic tests can give doctors more detailed information than ever about their patients. Genetic information can help them decide whether their lymphoma patients would respond better to surgery, chemotherapy or radiation treatment; make more accurate diagnoses of abnormal cells or tissues; and more readily detect serious autoimmune disorders.
Read the rest of the article at The New York Times site--Genetic Tests Offer Promise, but Raise Questions, Too
Pew is no longer active in this line of work, but for more information, visit the Genetics & Public Policy Center Web site or visit the Genetics and Public Policy Centeron PewHealth.org.